Recombinant Human CCNA2 Protein

CCNA2, a member of the cyclin family, plays a crucial role in the regulation of the cell cycle, particularly during the transition from the G1 phase to the S phase. This protein regulates the activity of cyclin-dependent kinase 2 (CDK2), thereby influencing DNA replication and cell proliferation. Research has shown that alterations in the expression of CCNA2 are associated with various cancers, underscoring its potential as a biomarker for oncogenesis and a target for therapeutic interventions. Understanding the structural and functional properties of CCNA2 can provide insights into its role in cell cycle regulation and mechanisms of tumorigenesis. Recent studies have focused on the recombinant expression and purification of CCNA2 to facilitate in-depth analyses of its biochemical functions and interactions with CDKs and other regulatory proteins. By producing CCNA2 in a controlled laboratory environment, researchers aim to elucidate its structural characteristics through techniques such as X-ray crystallography and NMR spectroscopy. These studies are pivotal for revealing the molecular mechanisms by which CCNA2 contributes to cell cycle control and its implications in cancer biology. The ongoing research in this area not only enhances our understanding of CCNA2's role in normal cellular functions but also holds promise for developing targeted therapies to combat diseases characterized by dysregulated cell cycle progression.